Carboplatin

cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)

Therapeutic Indications

Carboplatin is indicated for:

Small cell carcinoma of the lung

Irrespective of gender only Adults (18 years old or older)

Carboplatin is indicated for the treatment of small cell carcinoma of the lung.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 200-400 mg/m² once every 21 days

Advanced ovarian carcinoma of epithelial origin

Women only, only Adults (18 years old or older)

Carboplatin is indicated for the treatment of:

  • Advanced ovarian carcinoma of epithelial origin in:
    • first line therapy
    • second line therapy, after other treatments have failed.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 200-400 mg/m² once every 21 days

Contraindications

Active ingredient Carboplatin is contraindicated in the following cases:

Severe renal impairment (creatinine clearance of ≤30 ml per minute)

No gender/age discrimination

Εμβόλιο για τον κίτρινο πυρετό

No gender/age discrimination

Severe myelosuppression

No gender/age discrimination

Bleeding tumors

No gender/age discrimination